Application of ketamine, remifentanil and dexmedetomidine in obstetric anesthesia

the effects of ketamine, remifentanil and dexmedetomidine on mothers and neonates in obstetric anesthesia

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1800017125

Enrollment

Unknown

Registered

2018-07-12

Start date

2018-07-28

Completion date

Unknown

Last updated

2018-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstetric anesthesia

Interventions

Group 1:Ketamine Anesthesia

Group 2:Remifentanil Anesthesia

Group 3:Dexmedetomidine Anesthesia

Eligibility

Sex/Gender

Female

Age

20 Years to 45 Years

Inclusion criteria

Inclusion criteria: We included American Society of Anesthesiologists class I and II full-term pregnant women (gestational age 37-41 weeks)scheduled to aplly cesarean section

Exclusion criteria

Exclusion criteria: placenta previa, placental abruption, twins or multiple gestations, fetal structural/genetic anomaly ,maternal diseases

Design outcomes

Primary

Measure	Time frame
catecholamine;Vital signs;Apargar;	—

Countries

China

Contacts

Public ContactZhiqiang Yu

Tianjin Central Hospital of gynecology and obstetrics

13820761323@163.com+86 13820761323

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 20, 2026